Ultragenyx Pharmaceutical Inc. — Form 8-K
Filed October 19, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 1/100
What the filing says
This 8-K filing header shows Ultragenyx Pharmaceutical filed an 8-K on 2026-10-19 reporting under Item 8.01 (Other Events). The document metadata does not include the actual narrative content describing what event occurred, dollar amounts, counterparties, or business impact. Only the filing structure and administrative details are visible.
Why this rating
Filing structure only; no substantive event disclosed in provided text. Cannot assess materiality without actual disclosure content.
Extracted items
See more from October 19, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.